PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Inhibition of integrin alpha2beta1 ameliorates glomerular injury.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22440900 ↗2012Reported benefit

Inhibition of integrin alpha2beta1 ameliorates glomerular injury.

MouseChemical/toxinIntegrin alpha2-null and wild-type; BALB/c backgroundMale

Model: Adriamycin (doxorubicin) nephropathy and partial renal ablation

Integrin alpha2-null mice developed significantly less proteinuria and glomerulosclerosis in both models, and pharmacological inhibition of integrin alpha2beta1 significantly reduced adriamycin-induced proteinuria, glomerular injury and collagen deposition in wild-type mice.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.